ALLISON HEATHER SAYLER CNP
Prescription History 1023723293
Nurse Practitioner in Adrian, MI

NPI Status: Active since January 20, 2023

Contact Information

777 KIMOLE LN STE 210
ADRIAN, MI
ZIP 49221
Phone: (517) 366-5020
Fax: (517) 366-5024

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ALLISON HEATHER SAYLER CNP, an active Nurse Practitioner specialist practicing in Adrian, MI. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 205 documented patient claims. Among these therapy options, the most frequently utilized medication is Bupropion Xl, which accounts for 59 claims alone.

Medication Index

No matching medications currently found on file.

Bupropion Xl

Generic Formulation: Bupropion HclSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 59
30-Day Fills 139.0
Days Supply 4,157
MI State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills70.7
Peer Average Days Supply2,104
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 68.6% higher than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,898.87 across this reporting matrix range.

Provider Avg Cost Per Claim

$49.13

State Avg Cost Per Claim

$45.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Bupropion is used to treat depression. It can improve your mood and feelings of well-being. It may work by helping to restore the balance of certain natural chemicals (neurotransmitters) in your brain.

Mounjaro

Generic Formulation: TirzepatideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 29
30-Day Fills 33.5
Days Supply 952
MI State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills19.5
Peer Average Days Supply549
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 70.6% higher than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $34,345.56 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,184.33

State Avg Cost Per Claim

$1,134.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES MELLITUS.

Therapeutic Applications

Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes.

Naltrexone Hcl

Generic Formulation: Naltrexone HclSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 39
30-Day Fills 43.0
Days Supply 1,155
MI State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills24.3
Peer Average Days Supply686
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 85.7% higher than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,248.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$32.02

State Avg Cost Per Claim

$57.00

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to prevent people who have been addicted to certain drugs (opiates) from taking them again. It is used as part of a complete treatment program for drug abuse (such as compliance monitoring, counseling, behavioral contract, lifestyle changes). This medication must not be used in people currently taking opiates, including methadone. Doing so can cause sudden withdrawal symptoms. Naltrexone belongs to a class of drugs known as opiate antagonists. It works in the brain to prevent opiate effects (such as feelings of well-being, pain relief). It also decreases the desire to take opiates. Ask your doctor or pharmacist if you should have naloxone available to treat opioid overdose. Teach your family or household members about the signs of an opioid overdose and how to treat it. This medication is also used to treat alcohol abuse. It can help people drink less alcohol or stop drinking altogether. It also decreases the desire to drink alcohol when used with a treatment program that includes counseling, support, and lifestyle changes.

Ozempic

Generic Formulation: SemaglutideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 29
30-Day Fills 37.0
Days Supply 1,066
MI State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills51.5
Peer Average Days Supply1,505
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $29,893.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,030.80

State Avg Cost Per Claim

$1,350.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

Topiramate

Generic Formulation: TopiramateSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 49
30-Day Fills 60.0
Days Supply 1,781
MI State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills54.4
Peer Average Days Supply1,594
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 48.5% more claims than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $447.73 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.14

State Avg Cost Per Claim

$19.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.

Therapeutic Applications

Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like ALLISON HEATHER SAYLER CNP provides transparency into local medical care patterns within Adrian, MI.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Nurse Practitioner** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.